Anúncio
Anúncio
OLMA
Olema Pharmaceuticals, Inc. Common Stock
28.08
USDPatrocinado
+2.51
+9.83%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
28.18
+0.10
+0.36%
Relatórios de Lucros OLMA
Rácio de surpresa positiva
OLMA separação 11 de 20 últimas estimativas.
55%
Próximo Relatório
Data do Próximo Relatório
16 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.55
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+12.24%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+7.84%
Olema Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 10 de nov. de 2025, OLMA reported earnings of -0.49 USD per share (EPS) for Q3 25, beating the estimate of -0.49 USD, resulting in a 0.67% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.19% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analistas forecast an EPS of -0.55 USD, with revenue projected to reach -- USD, implying an aumentar of 12.24% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Olema Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Olema Pharmaceuticals, Inc. Common Stock reported EPS of -$0.49, beating estimates by 0.67%, and revenue of $0.00, 0% as expectations.
How did the market react to Olema Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 4.19%, changed from $8.35 before the earnings release to $8.70 the day after.
When is Olema Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 16 de mar. de 2026.
What are the forecasts for Olema Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 11
analistas, Olema Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.55 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio